MDGL Madrigal Pharmaceuticals

• None no insider bought on the open market
• None no sales outside a trading plan
• $61.5M sold by 8 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. William John Sibold CEO
   Planned sale
   $2.8M 5,221 shares at $542.39 2.6% of stake
   Traded Sep 11 Filed Sep 11
   ↗
3. David Soergel Chief Medical Officer
   Planned sale
   $517K 1,042 shares at $495.74 9.4% of stake
   Traded Jun 1 Filed Jun 1
   ↗
4. Richard S Levy Director
   Planned sale
   $2.9M 5,682 shares at $515.44 21% of stake
   Traded May 22 Filed May 22
   ↗
5. Mardi Dier CFO
   Planned sale
   $575K 1,336 shares at $430.36 9.7% of stake
   Traded Mar 6 Filed Mar 6
   ↗
6. Carole Huntsman Chief Commercial Officer
   Planned sale
   $282K 570 shares at $494.59 5.9% of stake
   Traded Jan 26 Filed Jan 26
   ↗
7. Shannon T Kelley General Counsel
   Planned sale
   $215K 429 shares at $501.40 4.8% of stake
   Traded Jan 20 Filed Jan 20
   ↗
8. Paul A Friedman Director
   Planned sale
   $154K 280 shares at $551.24 0.1% of stake
   Traded Jan 9 Filed Jan 13
   ↗
9. Paul A Friedman Director
   Planned sale
   $12.8M 24,520 shares at $522.39 12% of stake
   Traded Jan 9 Filed Jan 13
   ↗
10. Rebecca Taub Director
    Planned sale
    $132K 240 shares at $550.33 0.1% of stake
    Traded Jan 9 Filed Jan 13
    ↗
11. Rebecca Taub Director
    Planned sale
    $9.6M 18,410 shares at $522.40 3.9% of stake
    Traded Jan 9 Filed Jan 13
    ↗
12. Paul A Friedman Director
    Planned sale
    $13.7M 24,800 shares at $552.18 12% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
13. Rebecca Taub Director
    Planned sale
    $10.3M 18,650 shares at $552.15 3.9% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
14. Mardi Dier CFO
    Planned sale
    $2.4M 4,173 shares at $578.34 29% of stake
    Traded Dec 2, 2025 Filed Dec 3, 2025
    ↗
15. Carole Huntsman Chief Commercial Officer
    Planned sale
    $590K 1,064 shares at $554.91 9.6% of stake
    Traded Nov 21, 2025 Filed Nov 21, 2025
    ↗
16. Richard S Levy Director
    Planned sale
    $4.4M 8,500 shares at $520.96 29% of stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 39 sales to cover taxes, 14 stock grants, 13 option exercises, and 1 gift.